The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
2-(4-((4-benzylpiperazin-1-yl)methyl)phenyl)benzo[d]oxazole ID: ALA4474812
PubChem CID: 126961652
Max Phase: Preclinical
Molecular Formula: C25H25N3O
Molecular Weight: 383.50
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: c1ccc(CN2CCN(Cc3ccc(-c4nc5ccccc5o4)cc3)CC2)cc1
Standard InChI: InChI=1S/C25H25N3O/c1-2-6-20(7-3-1)18-27-14-16-28(17-15-27)19-21-10-12-22(13-11-21)25-26-23-8-4-5-9-24(23)29-25/h1-13H,14-19H2
Standard InChI Key: FWMODKNVZLANTI-UHFFFAOYSA-N
Molfile:
RDKit 2D
29 33 0 0 0 0 0 0 0 0999 V2000
28.0555 -17.7594 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.0543 -18.5790 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.7624 -18.9879 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.7606 -17.3506 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.4692 -17.7558 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.4740 -18.5790 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.2584 -18.8288 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
30.7384 -18.1600 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.2506 -17.4969 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
31.5536 -18.1521 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.9657 -18.8590 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.7822 -18.8546 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.1874 -18.1439 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.7702 -17.4363 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.9552 -17.4443 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.0046 -18.1380 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.4183 -18.8427 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
34.0124 -19.5507 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.4227 -20.2533 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.2402 -20.2516 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
35.6458 -19.5411 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.2339 -18.8323 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.6512 -20.9579 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.4656 -20.9495 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.8751 -21.6504 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.6887 -21.6423 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.0894 -20.9322 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.6705 -20.2289 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.8582 -20.2404 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
6 7 1 0
7 8 2 0
8 9 1 0
9 5 1 0
10 11 2 0
11 12 1 0
12 13 2 0
13 14 1 0
14 15 2 0
15 10 1 0
8 10 1 0
13 16 1 0
16 17 1 0
17 18 1 0
17 22 1 0
18 19 1 0
19 20 1 0
20 21 1 0
21 22 1 0
20 23 1 0
24 23 1 0
24 25 2 0
25 26 1 0
26 27 2 0
27 28 1 0
28 29 2 0
29 24 1 0
M END Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 383.50Molecular Weight (Monoisotopic): 383.1998AlogP: 4.81#Rotatable Bonds: 5Polar Surface Area: 32.51Molecular Species: NEUTRALHBA: 4HBD: ┄#RO5 Violations: ┄HBA (Lipinski): 4HBD (Lipinski): ┄#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 7.87CX LogP: 4.86CX LogD: 4.26Aromatic Rings: 4Heavy Atoms: 29QED Weighted: 0.49Np Likeness Score: -1.13
References 1. Srivastava P, Tripathi PN, Sharma P, Rai SN, Singh SP, Srivastava RK, Shankar S, Shrivastava SK.. (2019) Design and development of some phenyl benzoxazole derivatives as a potent acetylcholinesterase inhibitor with antioxidant property to enhance learning and memory., 163 [PMID:30503937 ] [10.1016/j.ejmech.2018.11.049 ]